Atlas Trials

Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19

Clinical trial NCT04808895 · UNKNOWN

Trial details

NCT number
NCT04808895
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19Thrombosis Pulmonary
Start date
2021-04-01
Primary completion
2021-07-01
Enrollment
204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.